SUZANNE RICHARDSON: Open Payments
NPI 1417068263 · PUYALLUP, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,401 in 74 payments from 13 companies in 2025. Trend: 2023 $2,520 · 2024 $1,075 · 2025 $1,401
Food & beverage: $1,381Education: $19
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $371 |
| Novartis Pharmaceuticals Corporation | 18 | $234 |
| GENZYME CORPORATION | 8 | $167 |
| Organon LLC | 6 | $99 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $97 |
| Amgen Inc. | 3 | $94 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $92 |
| Arcutis Biotherapeutics, Inc. | 5 | $76 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $62 |
| UCB, Inc. | 2 | $33 |
Products named: SKYRIZI, COSENTYX, DUPIXENT, RINVOQ, SILIQ, OTEZLA, ILUMYA, VTAMA.
Industry payments across WA — which companies pay providers there.
